These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16574708)

  • 1. Harm reduction: lessons learned from tobacco control.
    Munafò MR
    J Psychopharmacol; 2006 May; 20(3):329-30, discussion 331. PubMed ID: 16574708
    [No Abstract]   [Full Text] [Related]  

  • 2. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV; Heavner KK
    Biomarkers; 2009 Jul; 14 Suppl 1():79-84. PubMed ID: 19604065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. For alcohol alternatives, the science is not the hardest part.
    Room R
    J Psychopharmacol; 2006 May; 20(3):323-4, discussion 331. PubMed ID: 16574705
    [No Abstract]   [Full Text] [Related]  

  • 4. Alcohol alternatives--a goal for psychopharmacology?
    Ragan CI
    J Psychopharmacol; 2006 May; 20(3):325-6, discussion 331. PubMed ID: 16574706
    [No Abstract]   [Full Text] [Related]  

  • 5. "Alcohol alternatives: a goal for psychopharmacology?" by David J. Nutt.
    Cox WM
    J Psychopharmacol; 2006 May; 20(3):327-8, discussion 331. PubMed ID: 16574707
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harm reduction in tobacco control.
    Hedley AJ; McGhee SM
    J Public Health (Oxf); 2009 Mar; 31(1):15-6. PubMed ID: 19109342
    [No Abstract]   [Full Text] [Related]  

  • 8. Intoxicating spin-offs.
    Anderson P
    Addiction; 2014 May; 109(5):699-700. PubMed ID: 24720821
    [No Abstract]   [Full Text] [Related]  

  • 9. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
    Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
    Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco harm reduction strategies: the case for physical activity.
    deRuiter W; Faulkner G
    Nicotine Tob Res; 2006 Apr; 8(2):157-68. PubMed ID: 16766410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco harm reduction: how rational public policy could transform a pandemic.
    Sweanor D; Alcabes P; Drucker E
    Int J Drug Policy; 2007 Mar; 18(2):70-4. PubMed ID: 17689347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Would alternate tobacco products use be better than smoking?
    Martinet Y; Bohadana A; Fagerström K
    Lung Cancer; 2006 Jul; 53(1):1-4. PubMed ID: 16690160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harm reduction techniques for hookah (shisha, narghile, "water pipe") smoking of tobacco based products.
    Chaouachi K
    Med Hypotheses; 2009 Oct; 73(4):623-4. PubMed ID: 19628335
    [No Abstract]   [Full Text] [Related]  

  • 15. Charting the science of the future where tobacco-control research must go.
    Warner KE
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S314-7. PubMed ID: 18021905
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of dram shop liability and enhanced overservice law enforcement initiatives on excessive alcohol consumption and related harms, a commentary on a New Mexico perspective.
    O'Connor R
    Am J Prev Med; 2011 Sep; 41(3):347-9. PubMed ID: 21855751
    [No Abstract]   [Full Text] [Related]  

  • 17. What's new in nicotine & tobacco research?
    Hébert R
    Nicotine Tob Res; 2007 Jan; 9 Suppl 1():S1-5. PubMed ID: 17365720
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiologic perspectives on smokeless tobacco marketing and population harm.
    Tomar SL
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S387-97. PubMed ID: 18021914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The regulatory challenges in engineering a safer tipple.
    Hall W
    J Psychopharmacol; 2006 May; 20(3):321-2, discussion 331. PubMed ID: 16574704
    [No Abstract]   [Full Text] [Related]  

  • 20. Harm reduction or harm maintenance?
    Pierce JP
    Nicotine Tob Res; 2002; 4 Suppl 2():S53-4. PubMed ID: 12573168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.